Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)
Volume
51
Pagination
S518 - S518
DOI
10.1016/S0959-8049(16)31437-X
ISSN
0959-8049